Peregrine Asset Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $913K | Sell |
19,726
-100
| -0.5% | -$4.63K | 0.28% | 77 |
|
|
2025
Q1 | $1.21M | Sell |
19,826
-900
| -4% | -$54.9K | 0.45% | 63 |
|
|
2024
Q4 | $1.17M | Sell |
20,726
-2,738
| -12% | -$155K | 0.43% | 63 |
|
|
2024
Q3 | $1.21M | Buy |
23,464
+500
| +2% | +$25.9K | 0.42% | 69 |
|
|
2024
Q2 | $954K | Buy |
22,964
+7,310
| +47% | +$304K | 0.38% | 66 |
|
|
2024
Q1 | $849K | Hold |
15,654
| – | – | 0.34% | 71 |
|
|
2023
Q4 | $803K | Hold |
15,654
| – | – | 0.39% | 70 |
|
|
2023
Q3 | $909K | Buy |
+15,654
| New | +$909K | 0.47% | 54 |
|
|
2022
Q1 | – | Sell |
-68,534
| Closed | -$4.27M | – | 113 |
|
|
2021
Q4 | $4.27M | Buy |
+68,534
| New | +$4.27M | 1.74% | 23 |
|
|
2021
Q3 | – | Sell |
-63,764
| Closed | -$4.26M | – | 135 |
|
|
2021
Q2 | $4.26M | Buy |
+63,764
| New | +$4.26M | 1.94% | 17 |
|
|
2017
Q4 | – | Sell |
-66,462
| Closed | -$4.24M | – | 107 |
|
|
2017
Q3 | $4.24M | Sell |
66,462
-14,501
| -18% | -$924K | 2.23% | 19 |
|
|
2017
Q2 | $4.51M | Buy |
+80,963
| New | +$4.51M | 2.88% | 11 |
|